INFLIXIMAB BETA

UNII:	X95ZTP4AEK
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	INFLIXIMAB BETA
GSRS Full Record:	X95ZTP4AEK i

2639475-46-8
H-gamma1 heavy chain chimeric (1-450) [VH (Mus musculus IGHV6-6*02 (89.0%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT [8.10.11] (26-33.51-60.99-109)) (1-120) -Homo sapiens IGHG1*01 (100%) G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-disulfide with L-kappa light chain chimeric (1'-214') [V-KAPPA (Mus musculus IGKV5-48*01 (93.7%) -IGKJ4*01 (83.3%) K123>N (103'), I126>V (106'), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-S, glycoform alfa
HUMANIZED RECOMBINANT ANTI-TUMOR NECROSIS FACTOR ? MONOCLONAL ANTIBODY
Immunoglobulin G1, anti-(human tumor necrosis factor α) (human-Mus musculus monoclonal XTMAB-16 γ1-chain), disulfide with human-Mus musculus monoclonal XTMAB-16 κ-chain, dimer
Infliximab beta
immunoglobulin G1-kappa, anti-[Homo sapiens TNF (tumor necrosis factor, TNF superfamily member 2, TNFSF2, TNF-alpha, TNFA)], chimeric monoclonal antibody (infliximab beta)
infliximab beta [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

INFLIXIMAB BETA

Synonyms and Mappings

Resources